Owned and operated by Baba Kahn, a CF veteran 
Independent analytical report
Retatrutide 30 mg — Task 100127
Review the report details, original PDF and Janoshik verification record.
Report summary
- Compound
- Retatrutide
- Strength
- 30 mg
- Reported purity
- 99.797%
- Tested quantity
- 31.82 mg
- Report date
- January 29, 2026
- Janoshik task ID
- #100127
This January 2026 certificate reports 31.82 mg of Retatrutide at 99.797 percent purity, the highest purity figure across the four Retatrutide records held.
Analysis was conducted on 29 January following a common GLP-1 blind panel. One note on provenance: an earlier circulating copy of this certificate carried a transcription error in its sample field. The document published here is Janoshik’s corrected version, and the verification link opposite resolves to the laboratory’s own record so the text can be checked independently.
This certificate describes the submitted sample identified in the report. It does not establish clinical safety, efficacy, suitability for human or veterinary use, or the specifications of future inventory.
